References
- Nelson A. A., Woodard G. Severe adrenal cortical atrophy (cytotoxic) and hepatic damage produced in dogs by feeding 2, 2‐bis (parachlorophenyl)‐l, l‐dichloroethane (DDD or TDE). Arch Path 1949; 48: 387–394
- Cueto C., Brown J. H. V. Biological studies on an adrenocorticolytic agent and the isolation of the active components. Endocrinology 1958; 62: 334–339
- Bergenstal D. M., Hertz R., Lipsett M. B., Moy R. H. Chemotherapy of adrenocortical cancer with o,p' DDD. Ann Int Med 1960; 53: 672–682
- Hutter A. M., Kayhoe D. E. Adrenal cortical carcinoma: Results of treatment with o,p' DDD in 138 patients. AM J Med 1966; 41: 581–592
- Lubitz J. A., Freeman L., Okun R. Mitotane use in inoperable adrenal cortical carcinoma. JAMA 1973; 223: 1109–1112
- Hajjar R. A., Hickey R. C., Samaan N. A. Adrenal cortical carcinoma. A study of 32 patients. Cancer 1975; 35: 549–554
- Hogan T. F., Citrin D. L., Johnson B. M., Nakamura S., Davis T. E., Borden E. C. o,p'‐DDD (Mitotane) therapy of adrenal cortical carcinoma. Observations on drug dosage, toxicity and steroid replacement. Cancer 1978; 42: 2177–2181
- Schteingart D. E., Motazedi A., Noonan R. A., Thompson N. W. Treatment of adrenal carcinomas. Arch Surg 1982; 117: 1142–1146
- Van Slooten H., Moolenaar A. J., Van Seters A. P., Smeenk D. The treatment of adrenocortical carcinoma with o,p' DDD: Prognostic implications of serum level monitoring. Eur J Cancer Clin Oncol 1984; 29: 47–53
- Luton J. P., Mahoudeau J. A., Bouchord P., Thieblot P., Hautconverture M., Simon D., Laudat M. H., Touitou Y., Bricaire H. Treatment of Cushing's syndrome by o,p' DDD. Survey of 62 cases. N Engl J Med 1979; 300: 459–464
- Schteingart D. E., Tsao H. S., Taylor C. I., McKenzie A., Victoria R., Therrien B. A. Sustained remission of Cushing's disease with mitotane and pituitary irradiation. Ann Int Med 1980; 92: 613–619
- Moy R. H. Studies of the pharmacology of o,p' DDD in man. J Lab Clin Med 1961; 58: 296–304
- Shevchenko A. V., Korpachev V. V. Distribution characteristics of the adrenocortical function inhibitor chloditon (o,p' DDD) in the body. Fiziol Biokhim Patol Endokr Sist 1975; 5: 25–7
- Luton J. P., Thieblot P., Valcke J. C., Mahouideau J. A., Bricaire H. Reversible gonadotropin deficiency in male Cushing's disease. J Clin Endocrol Metab 1977; 45: 488–495
- Gabrilove J. L., Nicolis G. L., Sohval A. R. The testis in Cushing's syndrome. J Urol 1974; 112: 95–99
- Whorton D., Krauss R. M., Marshall S., Milby T. H. Infertility in male pesticide workers. Lancet 1977; 2: 1259–1261
- Lipshultz L. I., Ross C. E., Whorton D., Melby T., Smith R., Joyner R. E. Dibromochloropropane and its effect on testicular function in man. J Urol 1980; 124: 464–468
- Marek J., Motlik K. Ultrastructure of acute adrenoortical damage due to aminoglutethimide (Elipiten Ciba) in rats. Virchows Archiv B Cell Path 1978; 27: 173–187
- Starka L., Motlik K., Marek J. Failure of aminoglutethimide to produce changes in morphology and steroid biosynthesis of rat testicles. Endocrinologia Experimentalis 1972; 6: 165–170
- Young R. B., Bryson M. J., Sweat M. L., Street J. C. Complexing of DDT and o,p' DDD with adrenal cytochrome P‐450 hydroxylating systems. J Steroid Biochem 1973; 4: 585–591
- Andrews L. S., Menard R. H., Maling H. M., Gillette J. R. The effect of o,p' DDD (Mitotane) administration on mitochondrial and microsomal cytochrome P‐450 in adrenal of male dogs. Fed Proc Fed Am Soc Exp Biol 1978; 37: 644
- Menard R. H. Inhibition of o,p' DDD (Mitotane) induced adrenal atrophy and necrosis by spironolactone administration. Proc Am Assoc Cancer Res 1978; 19: 148
- Benson W. R. The chemistry of pesticides. Ann NY Acad Sci 1969; 160: 7
- Touitou Y., Bogdan A., Legrand J. C., Desgrez P. Metabolism of o,p' DDD (Mitotane) in humans and animals. Current notions and practical deductions. Ann Endocrinol 1977; 38: 13–25
- Payne A. H., Quinn P. G., Sheela Rani C. S. Regulation of microsomal cytochrome P‐450 enzymes and testosterone production in Leydig cells. Recent Prog Horm Res 1985; 41: 153–197
- Abelson D., Bulaschenko H., Trommer P. R., Valdes‐Dakena A. Malignant interstitial‐cell tumor of the testis treated with o,p' DDD. Metabolism 1966; 15: 242–256